Live Webcast:
Life Disrupted: Role of Advanced Practice Providers in Guiding Patients with Crohn’s Disease Through the Challenges of Bowel Urgency
Up to 80% of patients with Crohn’s disease (CD) report some degree of bowel urgency, a symptom that not only significantly adds to their overall emotional and social burden but can be an indicator of uncontrolled bowel inflammation. Unfortunately, bowel urgency is largely underrecognized by health care professionals (HCPs) caring for patients with CD. Nurse practitioners (NPs) and physician associates (PAs) in the gastroenterology field are positioned to initiate screening for bowel urgency as part of thorough symptom evaluation while establishing open communication with patients and implementing shared decision-making.
In this CME Outfitters live webcast, leading clinical experts will help prepare learners to discuss, assess, and address bowel urgency in patients with CD, and will provide insight into the efficacy and safety of new and emerging therapies. The webcast will also include videos capturing the patient journey and first-hand experiences.
Register here:
CMEO Webcast
Live Webcast: Wednesday, May 1st, 2024 at 6:30 pm EST
This activity offers CME credit for:
Pharmacists (ACPE) 1.0
PAs (AAPA) 1.0
Credit Expiration Date: 07/01/2024
By entering your mobile phone number you agree that CME Outfitters can send you periodic text messages about CME/CE activities. This free service is FCC CAN-SPAM compliant. You may update message preferences or unsubscribe at any time. Check your wireless provider for any message and data rates that may apply.
Expert Faculty

Kimberly Orleck, PA-C (Moderator)

Amar Naik, MD

Susan T. Wolgamott, DNP, FNP-C, CTN-B
Learning Objectives
At the conclusion of this activity, learners will be able to better:
- Identify the contributions of bowel urgency, fatigue, psychosocial symptoms, and histologic/endoscopic healing in the burden of CD and their effects on patient QoL
- Evaluate bowel urgency, fatigue, psychosocial symptoms, and histologic/endoscopic healing for patients with CD as part of thorough symptom evaluation
- Engage patients in open communication about their bowel urgency, fatigue, psychosocial symptoms, and histologic/endoscopic healing with the goal of improving clinical outcomes
Financial Support
This activity is supported by an educational grant from Lilly.
Target Audience
Primary: gastroenterology nurse practitioners (NPs) and physician associates (PAs)Secondary: nurses and pharmacists
Interprofessional (IPCE) 1.0
Physicians (ACCME) 1.0
Nurses (ANCC) 1.0
Pharmacists (ACPE) 1.0
PAs (AAPA) 1.0
Disclosure Declaration
Ms. Orleck reports the following financial relationships:
Advisory Board: AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Lilly; and Salix Pharmaceuticals
Consultant: Bristol Myers Squibb Company and Pfizer Inc.
Speakers Bureau: AbbVie Inc.; Ardelyx; Janssen Pharmaceuticals, Inc.; Lilly; Salix Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.
Dr. Naik reports the following financial relationships:
Consultant: AbbVie Inc.; Bristol Myers Squibb Company; Eli Lilly & Company; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Speakers Bureau: AbbVie Inc.; Bristol Myers Squibb Company; Eli Lilly & Company; and Takeda Pharmaceuticals U.S.A., Inc.
Dr. Wolgamott reports no financial relationships to disclose.
The following individuals have no financial relationships to disclose:
Amanda K. Smith, PA-C (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Susan Perry (Planning Committee)
Kasey Brandt, PharmD (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
Obtaining Credit
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.